Whole-Heart Tissue Engineering and Cardiac Patches: Challenges and Promises

• Published in: Bioengineering (Basel) Vol. 10; no. 1; p. 106
• Main Authors: Akbarzadeh, Aram, Sobhani, Soheila, Soltani Khaboushan, Alireza, Kajbafzadeh, Abdol-Mohammad
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12.01.2023; MDPI
• Subjects: Adenoviruses; Bioengineering; Bone marrow; cardiac patch; cardiac tissue engineering; Cardiomyocytes; Cardiovascular disease; Cell therapy; Clinical trials; decellularized extracellular matrix; Drug dosages; Efficiency; Extracellular matrix; Gene expression; Gene therapy; Growth factors; Heart; Hydrogels; In vivo methods and tests; Morbidity; Patches (structures); Proteins; Regeneration (physiology); Regenerative medicine; Review; Scaffolds; Stem cell transplantation; Stem cells; Thoracic surgery; Tissue engineering; Vectors (Biology); whole-heart regeneration; decellularized extracellular matrix; cardiac patch; cardiac tissue engineering; whole-heart regeneration
• ISSN: 2306-5354; 2306-5354
• DOI: 10.3390/bioengineering10010106

Despite all the advances in preventing, diagnosing, and treating cardiovascular disorders, they still account for a significant part of mortality and morbidity worldwide. The advent of tissue engineering and regenerative medicine has provided novel therapeutic approaches for the treatment of various diseases. Tissue engineering relies on three pillars: scaffolds, stem cells, and growth factors. Gene and cell therapy methods have been introduced as primary approaches to cardiac tissue engineering. Although the application of gene and cell therapy has resulted in improved regeneration of damaged cardiac tissue, further studies are needed to resolve their limitations, enhance their effectiveness, and translate them into the clinical setting. Scaffolds from synthetic, natural, or decellularized sources have provided desirable characteristics for the repair of cardiac tissue. Decellularized scaffolds are widely studied in heart regeneration, either as cell-free constructs or cell-seeded platforms. The application of human- or animal-derived decellularized heart patches has promoted the regeneration of heart tissue through in vivo and in vitro studies. Due to the complexity of cardiac tissue engineering, there is still a long way to go before cardiac patches or decellularized whole-heart scaffolds can be routinely used in clinical practice. This paper aims to review the decellularized whole-heart scaffolds and cardiac patches utilized in the regeneration of damaged cardiac tissue. Moreover, various decellularization methods related to these scaffolds will be discussed.